Matisse Capital - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Matisse Capital ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$132,000
+1.5%
17,6850.0%0.05%
+23.3%
Q2 2020$130,000
-36.6%
17,685
-36.1%
0.04%
-46.9%
Q1 2020$205,000
+147.0%
27,685
+88.5%
0.08%
+37.3%
Q4 2019$83,000
-3.5%
14,6850.0%0.06%
-44.3%
Q3 2019$86,00014,6850.11%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,831,474$23,410,0005.89%
AIGH Capital Management LLC 642,154$3,924,0000.71%
Ikarian Capital, LLC 1,095,024$6,690,0000.54%
Worth Venture Partners, LLC 163,994$1,002,0000.37%
Orbimed Advisors 4,797,148$29,311,0000.30%
RA Capital Management 2,731,170$16,687,0000.27%
J. Goldman & Co LP 720,877$4,405,0000.17%
DAFNA Capital Management LLC 38,891$238,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 124,827$763,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 102,200$624,0000.01%
View complete list of SCPHARMACEUTICALS INC shareholders